Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of Two Reduced Sirolimus Doses on the BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions(REDOX)

NCT00233766 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.

NCT NCT00233766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00233766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of Two Reduced Sirolimus Doses on the BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions(REDOX)
Lead sponsor
Cordis US Corp.
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2002
Completion date
December 31, 2007
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease